Durvalumab trials for Non-Small-Cell Lung Cancer

All Durvalumab trials · All Non-Small-Cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Durvalumab for Non-Small-Cell Lung Cancer

• A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
  NCT07554339 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 73 locations
• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
  NCT05211895 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 264 locations
• A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
  NCT04550104 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
  NCT07195695 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 202 locations
• Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
  NCT05061550 · Phase: Phase 2 · Ages: 18 Years to 95 Years · Sex: All (male and female) · 97 locations
• Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
  NCT04585490 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Durvalumab for Non-Small-Cell Lung Cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.